Galapagos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.About GLPG
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.
CEOPaulus Stoffels
CEOPaulus Stoffels
Employees1,338
Employees1,338
HeadquartersMechelen, Brussels Region
HeadquartersMechelen, Brussels Region
Founded1999
Founded1999
Employees1,338
Employees1,338
GLPG Key Statistics
Market cap2.13B
Market cap2.13B
Price-Earnings ratio9.49
Price-Earnings ratio9.49
Dividend yield—
Dividend yield—
Average volume111.32K
Average volume111.32K
High today$33.10
High today$33.10
Low today$31.88
Low today$31.88
Open price$32.15
Open price$32.15
Volume302.69K
Volume302.69K
52 Week high$45.21
52 Week high$45.21
52 Week low$31.86
52 Week low$31.86
GLPG News
TipRanks 49m
Galapagos NV Welcomes New Board MemberGalapagos NV (GLPG) has released an update. Galapagos NV has strengthened its board by appointing Andrew Dickinson, the Chief Financial Officer of Gilead Scien...
Analyst ratings
67%
of 12 ratingsBuy
33.3%
Hold
66.7%
Sell
0%